Article Information
History
- September 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Diana Lin1,*,
- Kareem A. Wahid2,*,
- Benjamin E. Nelms3,
- Renjie He2,
- Mohammed A. Naser2,
- Simon Duke4,
- Michael V. Sherer5,
- John P. Christodouleas6,7,
- Abdallah S. R. Mohamed2,
- Michael Cislo1,
- James D. Murphy5,
- Clifton D. Fuller2,** and
- Erin F. Gillespie1,**
- 1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 2Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3Canis Lupus, LLC, Merrimac, WI, USA
- 4Department of Radiation Oncology, Cambridge University Hospitals, Cambridge, UK
- 5Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
- 6Department of Radiation Oncology, The University of Pennsylvania Cancer Center, Philadelphia, PA, USA
- 7Elekta, Atlanta, GA, USA
- ↵**co-corresponding authors Corresponding authors:
Clifton D. Fuller, MD, PhD, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Houston, TX, 77030, Email: cdfuller{at}mdanderson.org, Erin F. Gillespie, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10065, Email: efgillespie{at}ucsd.edu